Institutional investors hold a majority ownership of DEPO through the 105.05% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended March 2015, these large investors purchased a net $9.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VANGUARD INVESTMENTS AUSTRALIA L... Bought 3.3 Thousand shares of Depomed Inc
STATE STREET GLOBAL ADVISORS LTD... Bought 419.00 shares of Depomed Inc
JCI CAPITAL LTD. Bought 372.00 shares of Depomed Inc